A New Drug of Choice for HIV Treatment in the Philippines
In a an online summit held on December 3, 2020 at The Club United in Parañaque City, streamed thru a video conferencing, Dr. Ditangco introduced the promising effects of Dolutegravir or DTG, the newly–identified ARV (anti–retroviral) drug in slowing down the replication of the Human Immunodeficiency Virus (HIV) inside the human body. DTG now stands to be the preferred treatment option across all populations.